Christopher P Kellner, MD
img_Christopher P Kellner
Are you a patient?
Research Topics
Regeneration, Rehabilitation, Stem Cells, Stroke

MD, Columbia University College of Physicians & Surgeons

Residency, Neurosurgery, Columbia University Neurological Surgery


American Board of Neurological Surgery
Recognition and Management of Acute Stroke
Visor Helps Determine If Someone Suffered Stroke

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Kellner during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Company Founder:

  • Metis Innovative, LLC
  • Precision Recovery Corp

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • Metis Innovative, LLC
  • Precision Recovery Corp

Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • E8
  • Fluid Biomed
  • Von Medical
  • Borvo
  • Synchron
  • Proprio

Service on Board of Directors: Service in a fiduciary capacity, such as an officer or director, for the following companies:

  • Precision Recovery Corp

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.